Animal Health Industry: Michael Castor’s Next Promising Pick Is Here
Animal health industry: There are hundreds of different "investment gurus" lauded by the financial press as the names retail investors should pay attention to.
Posts Tagged ‘NASDAQ:NPSP’
Cardinal Health, Inc. (CAH), NPS Pharmaceuticals, Inc. (NPSP), Anacor Pharmaceuticals Inc (ANAC): Checking Back In On Michael Castor’s Favorite Healthcare Trio
We discussed Michael Castor's Sio Capital earlier this summer, and in case you need convincing of why we called him "the next David Einhorn," give this April analysis a look...
Hedge Funds Are Betting On Celldex Therapeutics, Inc. (CLDX)
If you were to ask many market players, hedge funds are assumed to be overrated, old investment vehicles of a forgotten age.
Here is What Hedge Funds and Insiders Think About Puma Biotechnology Inc (PBYI)
In today’s marketplace, there are dozens of methods market participants can use to watch the equity markets.
Is Achillion Pharmaceuticals, Inc. (ACHN) Going to Burn These Hedge Funds?
To the average investor, there are dozens of indicators market participants can use to analyze their holdings.
NPS Pharmaceuticals, Inc. (NPSP): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
In today’s marketplace, there are tons of gauges market participants can use to track their holdings.
This MannKind Corporation (MNKD) Data Is Simply Jaw-Dropping. Wow.
MannKind Corporation (NASDAQ:MNKD) has gotten one of the biggest votes of confidence we've seen from the smart money, out of the entire stock market universe and the 500+ elite...
Alexion Pharmaceuticals, Inc. (ALXN), BioMarin Pharmaceutical Inc. (BMRN): 5 of the World’s Most Ultra-Rare Diseases
There are few times when your doctor or physician will utter the phrase, "I don't know" to a patient, but when you're dealing with the rarest of diseases, then all bets are off...
Apple Inc. (AAPL), Google Inc (GOOG): The Media is Dead Wrong About Hedge Funds
It’s time to set the record straight.
Michael Castor’s Sio Capital Knows How to Beat the Market: Cardinal Health Inc (CAH), Small Pharma & More
There are thousands of hedge funds in action today--about 8,000 to be exact--but there are those that stand out amongst the crowd.
American Realty Capital Properties Inc (ARCP), LIBERTY GLOBAL PLC (LBTYK) – Best Hedge Fund Managers: David Simon’s Stock Picks
We have read dozens of articles about hedge funds and hedge fund advertising over the last few weeks.
Aegerion Pharmaceuticals, Inc. (AEGR), NPS Pharmaceuticals, Inc. (NPSP): Three of the World’s Rarest Diseases (and the Uncommon Profits They Bring)
Imagine finding out that you have a disease that only a handful of people around the world have. Kirstie and Catherine Fields don't have to imagine it.
MannKind Corporation (MNKD): Are Hedge Funds Right About This Stock?
According to most stock holders, hedge funds are viewed as underperforming, old financial vehicles of the past.
Here is What Hedge Funds Think About Puma Biotechnology Inc (PBYI)
In the eyes of most traders, hedge funds are seen as worthless, old financial tools of the past.
Do Hedge Funds and Insiders Love Celldex Therapeutics, Inc. (CLDX)?
In the financial world, there are plenty of indicators market participants can use to track publicly traded companies.
NPS Pharmaceuticals, Inc. (NPSP), Pfizer Inc. (PFE): The Profitable Business of Developing Orphan Drugs
"Making every patient count" is a catchy phrase that is perhaps most meaningful for biotech companies like NPS Pharmaceuticals, Inc.
Achillion Pharmaceuticals, Inc. (ACHN): Are Hedge Funds Right About This Stock?
To most stock holders, hedge funds are seen as underperforming, old financial tools of years past.
NPS Pharmaceuticals, Inc. (NPSP): Hedge Funds and Insiders Are Bearish, What Should You Do?
If you'd ask most shareholders, hedge funds are assumed to be slow, outdated investment tools of the past.
NPS Pharmaceuticals, Inc. (NPSP), Vertex Pharmaceuticals Incorporated (VRTX): Double-Digit Returns from the Biotechnology Strategy
Investments in biotechnology by the average investor tend to deliver hit or miss returns over time.
Amgen, Inc. (AMGN), Regeneron Pharmaceuticals Inc (REGN), NPS Pharmaceuticals, Inc. (NPSP): Can These Biotechs Continue to Climb?
Two high-flying biotech stocks of late are NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN) .
Is MannKind Corporation (MNKD) Going to Burn These Hedge Funds?
MannKind Corporation (NASDAQ:MNKD) was in 8 hedge funds' portfolio at the end of December. MNKD shareholders have witnessed an increase in hedge fund interest of late.
Puma Biotechnology Inc (PBYI), Achillion Pharmaceuticals, Inc. (ACHN): Here is What Hedge Funds Think About NPS Pharmaceuticals, Inc. (NPSP)
According to most investors, hedge funds are perceived as worthless, old financial tools of years past.
Sio Capital’s Healthcare Stock Picks: Cardinal Health, Inc. (CAH), CareFusion Corporation (CFN), NPS Pharmaceuticals, Inc. (NPSP)
Hedge funds as a group have been underperforming the S&P 500 index for a very long time, and this doesn’t sit well with investors. The reason is simple.
Orphan Drug Is Headed Back to Its Parent: NPS Pharmaceuticals, Inc. (NPSP), Eli Lilly & Co. (LLY)
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) is bringing its kids home.
It’s Time for AstraZeneca plc (ADR) (AZN) to Save Its Future
The hits keep coming at AstraZeneca plc (ADR) (NYSE:AZN).
4 Orphan Drugs Making Waves in 2013: Sanofi SA (ADR) (SNY) and More
Orphan drugs -- medications meant for small patient populations with rare, dangerous diseases -- can be a rewarding business for biotech firms that strike gold.
3 Stocks to Get on Your Watchlist: NPS Pharmaceuticals, Inc. (NPSP) and More
I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated.
5 Health Care Stocks Slumping in 2013: NPS Pharmaceuticals, Inc. (NPSP), OraSure Technologies, Inc. (OSUR)
Stocks are rolling along unchallenged, surging to highs not seen since 2007.
